Trial
NCT03662685
Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
National Psoriasis Foundation
Condition
Psoriasis Vulgaris
Intervention
Goeckerman Therapy
Why stopped
Closing of the Goeckerman program at UCSF and loss of funding, PI left UCSF
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-03